EODData

MEMBERSHIP REGISTER LOG IN

NYSE, TEVA: Teva Pharmaceutical Industries ADR

06 Nov 25 17:21
LAST:

24.46

CHANGE:
 0.14		OPEN:
24.05		HIGH:
24.88		ASK:
29.12		VOLUME:
24.23M
CHG(%):
0.57		PREV:
24.60		LOW:
23.87		BID:
29.08		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Nov 2524.0524.8823.8724.4624.23M
05 Nov 2523.0625.0022.7024.6056.47M
04 Nov 2520.2620.7220.1120.4610.96M
03 Nov 2520.6020.8820.3120.5210.63M
31 Oct 2520.1720.6019.9820.489.38M
30 Oct 2520.1220.3820.0120.036.2M
29 Oct 2519.9720.6219.8920.2317.12M
28 Oct 2519.6819.9819.2319.789.49M
27 Oct 2519.1519.6819.0019.618.65M
24 Oct 2519.0719.1918.8818.955.21M

COMPANY PROFILE

Name:Teva Pharmaceutical Industries ADR
About:Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
Sector:Healthcare
Address:124 Dvora HaNevi?a St., Tel Aviv, Israel, 6944020
Website:https://www.tevapharm.com
CUSIP:881624209
CIK:0000818686
ISIN:US8816242098
FIGI:BBG000C0CD58
LEI:549300BAFGM4RC74ZJ94

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:22.1010.7%
MA10:20.9117.0%
MA20:20.2221.0%
MA50:19.6224.7%
MA100:18.2134.3%
MA200:17.2741.7%
STO9:89.98 
STO14:91.07 
RSI14:86.84 
WPR14:-2.48 
MTM14:5.04
ROC14:0.26 
ATR:0.85 
Week High:25.002.2%
Week Low:19.9822.5%
Month High:25.002.2%
Month Low:18.8341.7%
Year High:25.002.2%
Year Low:12.4796.2%
Volatility:23.14 

RECENT SPLITS

Date Ratio
01 Jul 20042-1
06 Dec 20022-1
23 Feb 20002-1
14 Apr 19932-1

RECENT DIVIDENDS

Date Amount
27 Nov 2017$0.09
25 Aug 2017$0.09
01 Jun 2017$0.34
28 Feb 2017$0.34
01 Dec 2016$0.34
18 Aug 2016$0.34
20 May 2016$0.34
25 Feb 2016$0.34
13 Nov 2015$0.34
18 Aug 2015$0.34